candoxatrilat has been researched along with n-formylmethionine leucyl-phenylalanine in 1 studies
Studies (candoxatrilat) | Trials (candoxatrilat) | Recent Studies (post-2010) (candoxatrilat) | Studies (n-formylmethionine leucyl-phenylalanine) | Trials (n-formylmethionine leucyl-phenylalanine) | Recent Studies (post-2010) (n-formylmethionine leucyl-phenylalanine) |
---|---|---|---|---|---|
46 | 10 | 1 | 6,716 | 53 | 356 |
Protein | Taxonomy | candoxatrilat (IC50) | n-formylmethionine leucyl-phenylalanine (IC50) |
---|---|---|---|
fMet-Leu-Phe receptor | Homo sapiens (human) | 0.02 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Amanaka, K; Kugiyama, K; Matsumura, T; Ohgushi, M; Sugiyama, S; Suzuki, M; Yasue, H | 1 |
1 other study(ies) available for candoxatrilat and n-formylmethionine leucyl-phenylalanine
Article | Year |
---|---|
Neutral endopeptidase 24.11 in neutrophils modulates protective effects of natriuretic peptides against neutrophils-induced endothelial cytotoxity.
Topics: Animals; Atrial Natriuretic Factor; Calcium; Cells, Cultured; Cyclic GMP; Cyclohexanecarboxylic Acids; Dogs; Endothelium, Vascular; Female; Humans; Male; Myocardial Infarction; N-Formylmethionine Leucyl-Phenylalanine; Natriuretic Peptide, Brain; Neprilysin; Nerve Tissue Proteins; Neutrophils | 1996 |